Enallylpropymal

Enallylpropymal

Clinical data
Other names	Enallylpropymal
ATC code	none
Identifiers
IUPAC name (RS)-1-Methyl-5-allyl-5-isopropyl-1,3-diazinane-2,4,6-trione
CAS Number	1861-21-8  Y
PubChem CID	95636
ChemSpider	86329
UNII	17BT2X209M
CompTox Dashboard (EPA)	DTXSID40871852
ECHA InfoCard	100.015.876
Chemical and physical data
Formula	C11H16N2O3
Molar mass	224.260 g·mol−1
3D model (JSmol)	Interactive image
Chirality	Racemic mixture
SMILES O=C1NC(=O)N(C)C(=O)C1(C(C)C)CC=C
InChI InChI=1S/C11H16N2O3/c1-5-6-11(7(2)3)8(14)12-10(16)13(4)9(11)15/h5,7H,1,6H2,2-4H3,(H,12,14,16) Key:AXJXURWWUFZZKN-UHFFFAOYSA-N
(verify)

Enallylpropymal (Narconumal) is a barbiturate derivative developed by Hoffman la Roche in the 1930s. ^[1] It has sedative and hypnotic effects and is considered to have a moderate abuse potential. ^[2]

References

1. US 2072829,Schnider O,"N-Methyl-5,5-allylisopropylbarbituric acid",issued 2 March 1937, assigned to Hoffmann-La Roche Inc. 
2. Eddy NB, Halbach H, Isbell H, Seevers MH (1965). "Drug dependence: its significance and characteristics". Bulletin of the World Health Organization. 32 (5): 721–33. PMC   2555251 . PMID   5294186.